Tagungen und Workshops zum Thema Pharmakologie und Arzneimittelentwicklung

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

ALLE LÄNDER

1.
 
World ADC Berlin — The 7th Annual World ADC Berlin
ID
845099
Termin
20. Feb 2017 - 22. Feb 2017
Ort
Berlin, Deutschland
Kontakt
Jenny Barlow;     Tel.: [+1 212 537 5898];     Email: info@hansonwade.com
Themen
Antibody drug conjugates, Antibody-drug conjugates, ADCs/ADC
Verwandte Fachgebiete
2.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811272
Termin
20. Feb 2017 - 22. Feb 2017
Ort
Baltimore, Vereinigte Staaten
Zusammenfassung
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Kontakt
James Martin;     Tel.: [1-302-231-6959];     Email: Vaccines@madrige.com
Themen
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
Verwandte Fachgebiete
3.
 
12th Annual Biomarkers Congress
ID
839676
Termin
21. Feb 2017 - 22. Feb 2017
Ort
Manchester, Großbritannien
Zusammenfassung
Oxford Global is proud to present its 12th Annual Biomarkers Congress taking place on the 21-22 February 2017 in Manchester. Our renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia.

In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics.

Kontakt
Danielle Dalby;     Tel.: [+44 1865248455];     Email: d.dalby@oxfordglobal.co.uk
Themen
Clinical development, clinical trials, clinical diagnostics, innovative biology, microRNA’s, CTCs, liquid biopsies and free circulating RNA & DNA.
Verwandte Fachgebiete
4.
 
DDRI — 3rd Drug Discovery Re-Invented (Emerging Role of Biotechs, Academics and Non-Profits)
ID
842984
Termin
21. Feb 2017 - 24. Feb 2017
Ort
Cancun, Mexiko
Kontakt
Jack Peters;     Tel.: [01638 724137];     Email: jack@fusion-conferences.com
Themen
drugs, drug, drug discovery, pharma, pharmacology, research, pipelines, government, academic, non-profits, biotech, pharmaceutical, innovation, natural products, drug development, structure, modeling, approaches
5.
 
Spotlight on Post Market Surveillance - By AtoZ Compliance
ID
879161
Beginn
23. Feb 2017
Ort
Webinar, Vereinigte Staaten
Zusammenfassung
This webinar will discuss the essentials of Post Market Surveillance, how you can develop your capabilities and how PMS can provide you with important information to improve your device, better service your customers, and reduce the risk of adverse events.

Post Market Surveillance (PMS) is the practice and system of monitoring the safety awareness training of a medical device after it has been released on the market.

It relies on several foundations including unique device identifiers (UDI), electronic health records and medical device reporting, device registries, and advance methods for evidence generation, data analysis and vigilance awareness training. It is a system that continues to develop and improve.

Kontakt
AtoZ Compliance;     Tel.: [8444141400];     Email: referrals@atozcompliance.com
Themen
pharmacovigilance training online, safety awareness training, vigilance awareness training, Post Market Surveillance and Vigilance Webinar
6.
 
Pharma Outsourcing & Partnership 2017 Europe
ID
873352
Termin
23. Feb 2017 - 24. Feb 2017
Ort
London, Großbritannien
Zusammenfassung
The global pharmaceutical industry is currently experiencing dynamic changes. Due to the high pressure of containing fixed costs all drug companies are reducing their internal capacities in R&D, marketing, manufacturing etc. in order to increase their outsourcing. Pharmaceutical companies big or small rely mainly on outsourcing service providers now more than ever to help solve problems, fulfil their tasks and improve efficiency and productivity. Thus it is crucial to create partnership opportunities to serve their individual needs. The two-day Pharma Outsourcing & Partnership Global Congress 2017 Europe will provide a unique platform for the convergence of stakeholders in the industry to interact, discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals and non-profit organizations as well as regional and local service providers to discuss and share on the outsourcing and partnership strategies, challenges and opportunities, global collaboration and the future of pharma outsourcing and partnership.
Kontakt
Jocelyn Raguindin;     Tel.: [02035671321];     Email: acarabeti@paradigmglobalevents.com
Themen
Accountable Partnership, UK Homecare Market, Pharma Market, Contract Giver vs. Contract Acceptor, Ideal Strategic Partnership, Partnership outside Europe, Clinical Trials, Risk of Outsourcing, CMC Development, IND Filing, Anti-Counterfeiting tactics, Patent Law, Multifaceted Approach Towards Product Lifecycle Stability, Biopharmaceutical and Biomedical Charity Sectors, Global Healthcare Budgets, Competitive Landscape of Outsourcing, Growth into the Emerging Markets, Pharma outsourcing and partnership strategies, Biggest challenges and opportunities in pharma outsourcing and partnership, Vendor relationship management, Changes in outsourcing and partnership, Legal and Regulatory issues, Overcoming outsourcing risks and counterfeiting, Global collaboration, Partnership between pharma companies and CRO industries, The future of pharma outsourcing and partnership
7.
 
2nd Annual Lyotalk 2017 Asia — Pacific Largest conference in Freeze drying / Lyophilization
ID
852224
Termin
23. Feb 2017 - 24. Feb 2017
Ort
HYDERABAD, Indien
Zusammenfassung
The event covers a wide spectrum from formulation, Development, Production, manufacturing and regulatory affairs topics such formulation strategies, Scale-up, cycle development & optimization, Regulatory compliance, Quality by Design (QbD) , PAT process design, Ice Nucleation, Case studies & troubleshooting, New developments in freeze drying, Process development for generics, proteins, biologics and vaccines.
Kontakt
Linda Clark;     Tel.: [+912265344333];     Email: linda.clark@biotrains.com
Themen
The main topics will include • Formulation strategies • Scale-up, cycle development & optimization • Regulatory compliance • Quality by Design (QbD) • PAT process design, • Ice Nucleation • Case studies & troubleshooting • New developments in freeze drying • Process development for generics, proteins, biologics and vaccines.
8.
 
Frontiers in Cancer Immunotherapy
ID
824403
Termin
27. Feb 2017 - 28. Feb 2017
Ort
New York, NY, Vereinigte Staaten
Zusammenfassung
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Themen
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
Verwandte Fachgebiete
9.
 
Disposable Solutions for Biomanufacturing
ID
859648
Termin
27. Feb 2017 - 01. Mär 2017
Ort
München, Deutschland
Zusammenfassung
By 2021 the knowledge and application of Single Use Systems will equal and even exceed that of Stainless Steel today. Where Disposable products and Single Use Technologies are becoming more widely used that ever before, this revolution has led to more questions than answers. In 2017, the 9th Annual event will bring you presentations from the main regulatory organisations plus panel discussions and case studies covering all aspects of disposables. Hear how to tackle all challenges from Particulates, Extractables and Leachables, System integrity, Implementation and more. This is the ONLY event that focuses on Single Use Technologies in biomanufacturing. For all your single use system questions, Disposable Solutions for Biomanufacturing Europe 2017 has the answers!
Kontakt
Rumina Akther;     Tel.: [+44 (0)207 036 1300];     Email: enquire@iqpc.co.uk
Themen
Single use systems, SUS, disposables, bioreactors, standardization, CMO, Good Manufacturing Practice, GMP facility, extractables and leachables, BPOG, BPSA
10.
 
Chemical Development & Scale-Up in the Fine Chemical & Pharmaceutical Industries
ID
858633
Termin
01. Mär 2017 - 03. Mär 2017
Ort
Pasadena, California, Vereinigte Staaten
11.
 
Seminar on the DHF, Technical File and Design Dossier - Similarities, Differences and the Future
ID
857645
Termin
02. Mär 2017 - 03. Mär 2017
Ort
Las Vegas, NV, Vereinigte Staaten
Kontakt
Event Manager;     Tel.: [(800) 447-9407];     Email: support@globalcompliancepanel.com
Themen
The Design History File, Device History Record, The Device Master Record, EU’s Medical Device Directive, Technical File Design Dossier, U.S. FDA’s DHF, FDA Compliance, FDA Regulations, Risk Analysis, Risk Management
12.
 
FDA's Regulation of Regenerative Medicine including Stem Cell Treatments, Tissue Engineering and Gene Therapies
ID
876730
Termin
02. Mär 2017 - 03. Mär 2017
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Stem cells harness the power to differentiate into numerous cells upon stimulation. This has led to their wide exploration across all of medicine, including high risk diseases. Of course, significant scientific breakthroughs in the use of stem cells to prevent, diagnose, and treat numerous diseases has caused numerous start-up companies to form. Despite, such promise, the FDA has yet to approve stem cell therapies for a wide range of diseases, except cord blood-derived hematopoietic progenitor cells for certain indications. This tutorial will provide an historical context for the use of stem cells in medicine, where the field has been and where it is going. It will also provide the few examples of FDA approved use of stem cells in medicine and what is needed for the field to progress. For example, in 2006, the U.S. FDA implemented regulations governing the use of human cells, tissues, and cellular and tissue-based products in humans including bone, ligament, skin, dura mater, stem cells, cartilage cells, and various other cellular and tissue-based products. Currently, there is an ongoing debate in industry on how such therapies should be regulated, in particular by the FDA or under the practice of medicine, under federal law or state law, and as drugs or simply biologics.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Regenerative medicine regulations, Stem Cell Treatments, biomaterials, FDA regulates regenerative treatments and therapies, good manufacturing
13.
 
Understanding the FDA's Regulation of HCT/Ps and Successful Product Development Strategies
ID
876795
Termin
02. Mär 2017 - 03. Mär 2017
Ort
Boston, Vereinigte Staaten
Zusammenfassung
In 1997, the FDA proposed a comprehensive regulatory program for Human Cells, Tissues and Cellular- and Tissue-Based Products (HCT/Ps) outlining the registration and listing procedures for HCT/Ps. This program also differentiates between HCT/Ps that will be regulated via the traditional pathway and those that will undergo approval as new drugs, biologics or devices. In this seminar, we'll discuss the historical context for the use of HCT/Ps in medicine as well as how the HCT/P market is evolving. You will be shown examples of the FDA-approved use of HCT/Ps and what is required for successful product development. This course will also provide an overview of the health authority regulating HCT/Ps, discuss the regulations that govern HCT/Ps, discuss potential product development strategies and provide an overview of product development in the United States.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA regulatory oversight of HCT/Ps, tissue reference group, approval process, good tissue practice, good manufacturing practice, quality system regulations
14.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825333
Termin
05. Mär 2017 - 09. Mär 2017
Ort
Breckenridge, Colorado, Vereinigte Staaten
Zusammenfassung
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
15.
 
BB17 — 3rd Biologics & Biosimilars Congress
ID
855011
Termin
06. Mär 2017 - 07. Mär 2017
Ort
Berlin, Deutschland
Zusammenfassung
This internationally respected congress is the networking meeting for those working in all areas of protein, antibody & biosimilar research. Executive panels and roundtables will foster discussion on the direction of the field, and the approaches required to ensure that the industry continues to flourish.
Kontakt
Jane Williams;     Tel.: [01865 849841];     Email: jane@globalengage.co.uk
Themen
Life Sciences/Biology, Health Sciences, Pharma
Verwandte Fachgebiete
16.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
828849
Termin
06. Mär 2017 - 10. Mär 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
17.
 
Recunnect Ltd — 3rd Anti-Counterfeiting Pharma Conference 2017
ID
870647
Termin
07. Mär 2017 - 08. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
We welcome you to be a part of Recunnect’s 3nd Anti-Counterfeiting Pharma Conference 2017 showcasing the anti-counterfeiting strategies for a better informed decision making. The aim is to foster discussion on how to tackle counterfeiting and improve patient safety. Gain the best insight into the most pressing challenges through practical advice on streamlining procedures and practices in the industry.
Kontakt
Sarika Sareen;     Tel.: [2071129183];     Email: marketing@recunnect.net
Themen
Drug, pharma, health, medicines,
18.
 
The A to Z's of Microbial Control, Monitoring and Validation of Water Systems for Pharmaceuticals, Biologics, Medical Devices, Cosmetics, and Personal Care Products
ID
876845
Termin
08. Mär 2017 - 09. Mär 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
All facilities manufacturing pharmaceuticals, biologics, medical devices, cosmetics, and personal care products are likely to have high purity water systems. In spite of this purity, microorganisms can flourish within these systems and lead to undesirable contamination of facility processes and their products. Of all the individuals at the facility, it is site’s microbiologists who should understand the microorganisms in water systems and how best to monitor and control them. Sadly, this is often not the case due to the lack of familiarity with biofilm and its impact on water system sampling, testing, sanitization, and routine maintenance. This lack of understanding of microbial control often leads to poor system designs, poor system sampling, poor system maintenance and poor sanitization practices, and as a result, ongoing microbial problems with the water.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Pharmaceutical water systems seminar, water system compliance seminar, water system microbial control, water system microbial monitoring, water system validation
19.
 
Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices
ID
876757
Termin
09. Mär 2017 - 10. Mär 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
Federal regulation of the advertising and promotion of pharmaceuticals and medical devices reflects an aggressive attitude on the part of the regulators that demands, in turn, that industry be keenly aware of the legal and regulatory duties, as well as key recent trends in enforcement activities by the Federal Government. This course will explore in detail what FDA requires of drug and device firms as well as recent current hot buttons in FDA enforcement activity for the advertising arena.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA training seminar, FTC advertising seminar, advertising drugs, advertising medical devices, promotion drugs, promoting medical devices
20.
 
FDA's New Import Program for 2017 - Strict Precision
ID
876782
Termin
09. Mär 2017 - 10. Mär 2017
Ort
Orlando, Vereinigte Staaten
Zusammenfassung
The FDA continues to change its import program to better manage new problems and to use new procedures to make the whole process easier. The FDA and U.S. Customs and Border Protection (CBP) are relying more and more on computer programs to expedite the import process. When and how you use these programs can make a big difference in the net profit derived from even a single shipment. The new Voluntary Qualified Importer Program (VQIP) is one such example. Another example is CBP’s and FDA’s implementation of the Automated Commercial Environment (ACE) program became mandatory for importers in 2016. If you fail to correctly use new import procedures and programs, you will be operating under an expensive disadvantage.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA import regulations, FDA’s import legal requirements, U.S. Customs and Border Protection, CBP requirements, FDA warning letter, FDA import program
21.
 
Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters
ID
876949
Termin
09. Mär 2017 - 10. Mär 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
Learn essentials of USP microbiology - reading between the lines of the USP general and information microbiology chapters. Explore Form FDA 483s and Warning Letters for microbiological applications.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
USP Microbiology, USP microbiology chapters, USP general, USP General Chapter Changes, USP Chapters, USP document
22.
 
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
ID
876854
Termin
13. Mär 2017 - 14. Mär 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
Raw material requirements in a cGMP environment are often overlooked as a company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Raw material requirements in a cgmp environment training, compendial and non-compendial testing, ASQ on sample size, ICH Q9, health canada requirements
23.
 
Pharmaceutica 2017 — 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
833088
Termin
13. Mär 2017 - 15. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day event: unique in format, content, networking and engagement. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional formulation and delivery mind-set and will help you to better understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform formulation and drug delivery.
Kontakt
Renaldo Howell;     Tel.: [+1 702 508 5200];     Email: renaldohowell179@gmail.com
Themen
Pharmaceutics, Drug Delivery, Targeted Drug Delivery, Formulation, Pharmaceutical nanotechnology, nanomedicine, smart drug delivery
24.
 
Health Economics for Non-Health-Economists
ID
834374
Termin
16. Mär 2017 - 17. Mär 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
25.
 
Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)
ID
876711
Termin
16. Mär 2017 - 17. Mär 2017
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
Today, many companies operate on an outsourcing model. This is very common for companies who are evolving from being mainly development-focused to a point where they are entering latter stages of Phase 2 or Phase 3 clinical trials, and plan to have a product ready for market approval in the coming months. Most such companies are small, and may not have deep expertise in QA and GMP compliance, relying on their partners to cover those areas. Companies who outsource the majority of operations through the use of Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and Contract Laboratories, however, remain responsible for the quality and compliance status of the products they send to the clinic or to the marketplace. Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
GMP compliance for virtual companies, contract manufacturing organizations (CMOs), contract research organizations (CROs), Contract Laboratories, quality agreement
26.
 
2nd Personalized Medicine Conference
ID
853010
Termin
17. Mär 2017 - 20. Mär 2017
Ort
Cancun, Großbritannien
Zusammenfassung
Join us for the 2nd Personalized Medicine conference taking place from 17-20 March 2017 in Cancun, Mexico to discuss to discuss precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data. The personalized medicine space has been defined by recent regulatory approvals of targeted therapeutics in oncology and co-developed diagnostics used in patient selection. However, a broader view of personalized medicine encompasses other disease areas, newer therapeutic regimens, new therapeutic platforms and broad computational approaches. This conference will weave together many of these new approaches and their relevance to personalized medicine.
Kontakt
Laura Trundle;     Tel.: [+44 (0) 1638724137];     Email: laura@fusion-conferences.com
Themen
precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data.
Verwandte Fachgebiete
27.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825257
Termin
19. Mär 2017 - 22. Mär 2017
Ort
Tahoe City, California, Vereinigte Staaten
Zusammenfassung
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Verwandte Fachgebiete
28.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825285
Termin
19. Mär 2017 - 23. Mär 2017
Ort
Whistler, British Columbia, Kanada
Zusammenfassung
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
Verwandte Fachgebiete
29.
 
ITOC4 — 4th ImmunoTherapy of Cancer Conference
ID
848908
Termin
20. Mär 2017 - 22. Mär 2017
Ort
Prag, Tschechische Republik
Zusammenfassung
The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy. The fourth edition (ITOC4) will take place on Prague, Czech Republic, from 20 to 22 March 2017. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Kontakt
Catherine Tomek (Congress Office);     Tel.: [+431405138318];     Email: itoc@medacad.org
Themen
Preclinical models, Co-stimulatory agonists and co-inhibitory antagonists, Immunogenomics, Therapeutic modulation of immune checkpoints, Combination therapy, Anti-cancer vaccines, Engineered T-cell therapy, Monitoring of immunotherapy
Verwandte Fachgebiete
30.
 
8th Annual Biotherapeutics Analytical Summit
ID
829849
Termin
20. Mär 2017 - 23. Mär 2017
Ort
Bethesda, Vereinigte Staaten
Zusammenfassung
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Kontakt
Bethany Gray;     Tel.: [781-972-5400];     Email: chi@healthtech.com
31.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858719
Termin
21. Mär 2017 - 23. Mär 2017
Ort
Nice , Frankreich
32.
 
CMC Documentation & Post-Approval Changes/Variations
ID
854521
Termin
22. Mär 2017 - 23. Mär 2017
Ort
Frankfurt, NH Frankfurt Niederrad, Deutschland
Zusammenfassung
Do you work in regulatory affairs/CMC or quality assurance? Then you shouldn’t miss out on this event. This conference will address very practical questions and provide strategic information on future CMC trends. Join the in-depth discussion on new developments, including: requirements for drug substance and drug product, elemental impurities and stability, ASMF worksharing, GMP inspection and QP declaration, quality documentation of IMPs, quality risk management, management of post-approval CMC changes and much more.
Kontakt
Laura Vogelmann;     Tel.: [+49 6221 500-655];     Email: l.vogelmann@forum-institut.de
Themen
quality management, regulatory affairs, vigilance, drug substance and drug product in Module 3, how to implement ICH Q3D?, ASMF worksharing, QP declaration and GMP inspection, post-approval change management, CMC part of the IMPD
33.
 
Root Cause Analysis and CAPA using 8-D Problem Solving Method
ID
876842
Termin
22. Mär 2017 - 23. Mär 2017
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Errors and defects are a problem in virtually every industry. The goal of defect-free/error-free product or service delivery is the aim of every company. However, in order to eliminate defects or errors permanently, you must use a disciplined approach in order to ensure that the problem does not recur. One of the most widely-used tools is the 8 Disciplines (8D) methodology. 8D requires you to identify and fix the problem immediately (put a bandaid on it) while identifying the Root Cause(s), and take steps to address the problem in the short term as well as in the long term (permanent fix).Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
8-D Reporting, Reporting and Problem-Solving Technique, Root Cause Analysis, 8 Disciplines (8D) method, 8D framework, 8D technique, Root Cause Analysis (RCA)
34.
 
CSS 2017 — Cool Supply System & Solutions 400+ 6th Annual Meeting 2017
ID
854257
Termin
23. Mär 2017 - 24. Mär 2017
Ort
Brüssel, Belgien
Zusammenfassung
Over 400 attendees at the GDP Brussels Cool Chain conference, 6th annual meeting time and temperature pharma controlled logistics.
Kontakt
Jessica Dobson;     Tel.: [+44 (0) 207 096 1152];     Email: Jessica.dosbson@businessdialogue.net
Themen
time and temperature, drug sensitive logistics, thermal packaging passive active, pharmaceutical logistics, logistics in pharmaceutical industry, reverse logistics in pharmaceutical industry, pharma distribution, pharma transport, cool chain logistics, European Cool chain conference 2017 Frankfurt Cool chain conference, IQPC Arena Cool chain conference, Brussels Cool Chain 2017, CSS 2017, Pharmaceutical supply chain conference, Drug Distribution, Last mile Movianto, Temperature controlled shipment, Pharma shippers Validation, Transport Pharma validation, Pharma logistics Brussels Airport, IATA CEIV Pharma Handling Validate, Good Distribution Practice Event, Pharma EU GDP conference, GDP quality system management, management review and monitoring of medicinal logistics, Pharma logistics quality risk management, the role of qualified person, validation of containers, qualification of storage or thermal mapping, Pharma 3pl, falsified medicinal products, drug integrity, Cool Chain Europe 2017
35.
 
Managing Your FDA Inspection: Before, During and After
ID
876797
Termin
23. Mär 2017 - 24. Mär 2017
Ort
Chicago, Vereinigte Staaten
Zusammenfassung
FDA inspects many different kinds of firms. If the FDA regulates your product, they can show up at your lobby and say, “I am here to conduct an inspection.” What do you do? What have you done to prepare for an inspection? How do you deal with the investigator, including their personality? The scary part is having to explain the error of your ways to the FDA and above all, managing an administrative action, e.g., Warning Letter or Import Alert, or a legal action, e.g., civil money penalties, seizure, injunction or prosecution. This course will help you need to know and what you should do to survive an FDA inspection with the least possible pain.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA inspection seminar, FDA inspection, FDA 483, FDA warning letter, FDA investigator, FDA law, Regulatory Sanctions used by FDA, Prohibited Acts
36.
 
Creating FDA Compliant SOPs — FDA Compliant SOPs for Regulated Industry: How to Create High Quality SOPs that Your Team and FDA Auditors Will Love
ID
879397
Termin
23. Mär 2017 - 24. Mär 2017
Ort
Boston, Vereinigte Staaten
Zusammenfassung
SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. This workshop is applicable to all FDA-regulated organizations: clinical trials, manufacturing, advertisement, marketing, regulatory affairs, auditing, and laboratory testing.
Kontakt
Peter Brown;     Tel.: [+1 410 501 5777];     Email: pbrown@fdamap.com
Themen
FDA SOP, FDA Compliance, FDA Audit, FDA Inspection, FDA Regulations, FDA 483, FDA Warning Letters, Standard Operating Procedures
37.
 
Keystone Symposia - HIV Vaccines
ID
825225
Termin
26. Mär 2017 - 30. Mär 2017
Ort
Steamboat Springs, Colorado, Vereinigte Staaten
Zusammenfassung
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Verwandte Fachgebiete
38.
 
Drug Discovery 2017 — Drug Discovery 2017
ID
853327
Termin
27. Mär 2017 - 28. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
The conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. Highlights include: discussions on the use of CRISPR/Cas9 Technology in target discovery, hit finding and translational studies; optimising the success of phenotyping screening; exploring whether translational medicine is capable of increasing success rate in pharma; insights into receptor activation from agonist and antagonist structures; and applications of enabling chemistry technology to the acceleration of the drug discovery process. Speakers include Sanofi, Takeda, AstraZeneca, Merck Serono, Novartis, AbbVie, GSK, Johnson & Johnson, UCB Pharma, Eli Lilly & Co and more. Register at http://www.drug-discovery.co.uk/coms
Kontakt
Honey de Gracia;     Email: hdegracia@smi-online.co.uk
Themen
drug discovery, drug development, stem cells, precise-genome editing, CRISPR/Cas9, phenotypic screening, translational medicine, receptor activation, agonist structures, drug design, computer aided drug design, fragment based drug design, SBDD, FBDD, CADD
39.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864054
Termin
29. Mär 2017 - 31. Mär 2017
Ort
London, Großbritannien
40.
 
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)
ID
876888
Termin
30. Mär 2017 - 31. Mär 2017
Ort
Tampa, Vereinigte Staaten
Zusammenfassung
The globalization of the pharmaceutical supply chain has led increased us of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it can present unique compliance risks, particularly since the operations are not in your facility and therefore not under your direct control. The compliance risks are highlighted by FDA Warning Letter trends, the majority of which are related to serious compliance and data integrity issues at foreign CMO sites.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
contract manufacturing pharmaceutical, CMO Oversight in Pharma Industry, CMO compliance, CMO business model, CMO Qualification Audit
41.
 
Understanding the Statistical Considerations for Quantitative ICH Guidelines
ID
876917
Termin
30. Mär 2017 - 31. Mär 2017
Ort
Orlando, Vereinigte Staaten
Zusammenfassung
This course is designed to introduce to individuals the understanding and interpretation of the statistical concepts with reference to certain quantitative ICH Guidelines that apply across laboratory (drug development) and clinical development (drug/device) procedures such as analytical methods in validation and acceptance criteria in calibration procedures, risk management and process monitoring as well as dealing with uncertainties and other relevant issues. It is not a course in statistics but introduces the participant to a hands on approach to the statistical techniques one uses, how they are applied and reasonably interpreted and understood. One will address the various challenges facing pharmaceutical and biotechnology companies when it comes to quantifying results in a meaningful interpretable manner through tabulations and graphical presentations. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Statistical considerations for quantitative ich guidelines training, quantitative measurement procedures, sensitivity of the sample size
42.
 
ICBMB 2017 International Conference on Biochemistry and Molecular Biology 3-5 April 2017, Munich, Germany
ID
853040
Termin
03. Apr 2017 - 05. Apr 2017
Ort
München, Deutschland
Kontakt
Andrea Berg;     Tel.: [adeo.office@gmail.com];     Email: adeo.office@gmail.com
Themen
biology, biochemistry, molecular biology
43.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858663
Termin
04. Apr 2017 - 06. Apr 2017
Ort
Verona, Italien
44.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811636
Termin
13. Apr 2017 - 16. Apr 2017
Ort
Girne (Kyrenia), Cyprus, Türkei
Verwandte Fachgebiete
45.
 
US GCP Fundamentals for Pharmaceutical and Biologic Companies
ID
876743
Termin
20. Apr 2017 - 21. Apr 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
Good Clinical Practice (GCP) is a term used to describe a collection of various FDA regulations that govern the conduct of clinical trials. It includes regulations which apply to Sponsors and Contract Research Organizations (CROs) who run the trials, the clinical trial sites and Investigators who conduct the research, the Institutional Review Boards (
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA GCP inspections, good clinical practices seminar, GCP compliance, clinical trial sites, IRBs, good manufacturing practice, GMP, FDA inspection management
46.
 
FDA Scrutiny of Promotion and Advertising Practices
ID
876750
Termin
20. Apr 2017 - 21. Apr 2017
Ort
Tampa, Vereinigte Staaten
Zusammenfassung
If you go
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
fda's advertising and promotion requirements, fda regulations for labelling, fda warning letter, fda legal authority, ftc, mass media, doj, off label, fda guidance
47.
 
Pharma Tech 2017 — International Conference and Exhibition on Pharmaceutical Development and Technology
ID
828931
Termin
24. Apr 2017 - 26. Apr 2017
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
ConferenceSeries LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe. ConferenceSeries LLC invites all the participants from all over the world to attend “International Conference and Exhibition on Pharmaceutical Development and Technology ”during April 24-26, 2017 Dubai, UAE.This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll.
Kontakt
Mythrei Syria;     Tel.: [+1-702-508-5200];     Email: pharmatech@pharmaceuticalconferences.com
Themen
Pharmaceutical Technology, Pharmaceutical Technology Conferences, Pharma Tech Meetings, Pharma Tech Symposiums, Pharma Tech Exhibitions, Pharma Tech 2017 Conferences, Pharma Tech Conferences Dubai, Pharma Tech meetings USA, Pharma Tech Conferences euro
Verwandte Fachgebiete
48.
 
Pharma Strategic Alliance Management — 7th Annual Strategic Alliance Management for Pharma
ID
871350
Termin
24. Apr 2017 - 26. Apr 2017
Ort
London, Großbritannien
Zusammenfassung
This marcus evans conference goes back to the fundamentals: how to structure the Alliance management internally, what are the responsibilities and roles of the Alliance function. With various types of collaborations, complex projects, it’s important for Alliance Management to be structured and to have the right tools available. We will also point out the value creation in the company and how evaluating alliances by measuring progress, bringing KPI and performance tools in the process. Structuring alliances is also to count on governance body and look at relations with steering committees, legal entities and contracts to effectively run alliances along their life cycle. The delegates will have the possibility to discuss, exchange and compare their methods but also meet various stakeholders of the life science panorama.
Kontakt
Constandinos Vinall;     Tel.: [+357 22 849 380];     Email: ConstandinosV@marcusevanscy.com
Themen
Implement the best practices in managing alliances, Improve alliance capabilities on the full alliances portfolio, Define and document common understanding and expectations with partners, Develop a set of tools to measure performance and objectives’ alignment, Choose the right partner according to the strategy and needs, Set mutual trust and keep the relationship in good conditions, Expand Alliance management framework across the organisation, Cope with unsuccessful partnerships and termination processes
49.
 
Corvus Global Events — Digi-tech Pharma 2017
ID
850927
Termin
25. Apr 2017 - 26. Apr 2017
Ort
London, Großbritannien
Zusammenfassung
Digital Pharma World 2017, will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. It will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of digital pharma. Also, to stay updated on the latest trends in digital, social media and mobile strategies required the overcome the obstructions in the transformation. This conference will allow IT leaders to share their technologies and strategies to help the pharma industries. The conference will offer opportunities to encourage partnerships and collaborations
Kontakt
Fazmina Fajjuu;     Tel.: [+44 (0) 207 096 0786];     Email: fazmina@corvusglobalevents.com
Themen
Key Highlights of the conference: • Digitally enabled business models • Big data analytics and pharma • Internet of things and pharma • Translational Informatics • Policy changes required for ensuring smooth transition • Ensuring regulatory compliance during the transformation • Digital marketing trends • Integrating Multichannel marketing and closed loop marketing • Digitalization of R& D using Big Data and IoT • New smart devices in manufacturing and supply chain • Clinical trials and digital world • Data management • Tools and strategies to engage with HCPs and patients and to win their confidence • Encouraging a customer–centric approach at all levels • Unrealized innovative potentials of digital era that pharma needs to focus on . Attendees includes VPs, GMs, Directors, Heads and Managers of • Pharma sales and Marketing • E-marketing • Digital innovative strategic planning • Regulatory and pharmacovigilance • IT consultants • Clinical trials and data management • Translational informatics • Data storage and analysis • Contract outsourcing service providers • Multi-channel Management • Health care professionals • Health IT professionals
50.
 
PFS East Coast — Pre-Filled Syringes East Coast
ID
854608
Termin
26. Apr 2017 - 27. Apr 2017
Ort
Boston, Großbritannien
Zusammenfassung
Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 4th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April 26th – 27th 2017 in Boston, Massachusetts, USA. Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS market professionals, providing a unique platform to discuss the latest innovations and developments in pre-filled syringes; as well as hone in on industry challenges and regulatory compliance. Featured speakers include AbbVie, Shire, Amgen, Eli Lilly, Allergan, Janssen, Merck and more!
Kontakt
Teri Arri;     Tel.: [2078276000];     Email: tarri@smi-online.co.uk
Themen
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd, drug delivery
Verwandte Fachgebiete
51.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864031
Termin
26. Apr 2017 - 28. Apr 2017
Ort
Berlin, Deutschland
52.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825408
Termin
01. Mai 2017 - 04. Mai 2017
Ort
Estes Park, Colorado, Vereinigte Staaten
Zusammenfassung
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Verwandte Fachgebiete
53.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864074
Termin
03. Mai 2017 - 05. Mai 2017
Ort
Dublin , Irland
54.
 
Navigating the Maze for Post-Market Compliance -- Complaint Handling, MDRs, Recalls and Proposed Guidance on FDA Risk Benefits
ID
878082
Termin
04. Mai 2017 - 05. Mai 2017
Ort
Pittsburgh, Vereinigte Staaten
Zusammenfassung
This interactive one and a half day course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief, who has more than 36 years’ experience with the FDA will provide the participants tools to minimize risk of regulatory enforcement actions. During the seminar, Ms. Hoffman will explain proper handling of complaints reportable or non-reportable, product complaint handling and documentation, how and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall. She will also discuss how to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
medical device recalls seminar, medical device regulations seminar, medical device reporting, medical device complaint management, medical device complaint handling
55.
 
3rd Annual Formulation & Drug Delivery Congress
ID
859618
Termin
08. Mai 2017 - 09. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are proud to present our 2017 3rd Annual Formulation & Drug Delivery Congress, taking place on 8 – 9 May 2017 in May in London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will have the opportunity to discuss over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery. Including 4 interactive streams: Large Molecule Drug Formulation; Small Molecule Drug Delivery; Small Molecule Drug Formulation and Large Molecule Drug Delivery.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
drug delivery, drug formulation, small molecule, large molecule
Verwandte Fachgebiete
56.
 
2nd Annual Inhalation & Respiratory Drug Delivery Congress
ID
873469
Termin
08. Mai 2017 - 09. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are proud to present our 2017 2nd Annual Inhalation & Respiratory Drug Delivery Congress, taking place on 8 – 9 May 2017 in London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will have the opportunity to discuss over 40 presentations and case studies focused on the key issues in inhalation and respiratory drug delivery. Including 4 interactive streams:Development & Formulation of Inhaled Therapies and Inhalation Devices & Analytics. Download Agenda Now: http://bit.ly/1NGMsPG. For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
inhalation drug delivery, respiratory drug delivery, inhalation devices, inhaled therapies
57.
 
Pharmaceutical Freeze Drying Technology
ID
877329
Termin
08. Mai 2017 - 09. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
Robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining product quality and biological stability. Innovation and efficiency is requested at every level making Pharmaceutical Freeze Drying Technology the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to growing manufacturing demands.

Gathering a room of Senior Scientists and Heads of Pharmaceutical Engineering, the 5th annual show provides an ideal forum to discuss the latest advancements in pharmaceutical lyophilisation, welcoming regulatory guidance from the NIBSC-MHRA and expertise from the likes of Sanofi, Boehringer Ingelheim, Roche, Novo Nordisk and more!

Kontakt
Teri Arri;     Tel.: [2078276000];     Email: tarri@smi-online.co.uk
Themen
lyophilisation, quality by design, freeze drying, scale-up, validation, spray drying, Process Analytical Techniques, PAT, robustness, stability, delivery, optimisation, protein stabilisation, design strategies, maintenance, automatic loading and unloading, lyophilization, qbd, protein, optimization, aseptic, fill/finish, temperature, drying, powder, nucleation, sterilization, injectables, thaw, storage, crystallization, formulation, parenteral, QBD, manufacturing
Verwandte Fachgebiete
58.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance
ID
828859
Termin
08. Mai 2017 - 12. Mai 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Michael Theodorakis, Radcliffe Department of Medicine, University of Oxford, and will feature face-to-face lectures and tutorials from some of the country's leading clinicians and scientists.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
59.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834302
Beginn
09. Mai 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
60.
 
E&L USA 2017 — Extractables & Leachables USA 2017
ID
854316
Termin
09. Mai 2017 - 11. Mai 2017
Ort
Falls Church, VA, Vereinigte Staaten
Zusammenfassung
Extractables and leachables examination is continuously growing in importance. Given the current scruitny paid by governing bodies including the FDA and EMEA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Kontakt
Emma Nweton;     Tel.: [+44 (0) 1372 802016];     Email: enewton@smithers.com
Themen
extractables, leachables, analytical chemistry, pharmaceuticals, drug development, drug delivery, regulations, quality assurance, single-use systems, risk assessments, packaging, drug packaging
61.
 
PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation
ID
878125
Termin
11. Mai 2017 - 12. Mai 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
The European Medicines Agency's (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness. It includes audit of the pharmacovigilance system which is covered by the quality system. The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis. The legally required risk based audit strategy shall cover all PV processes and tasks undertaken by or delegated to other departments, MAH affiliates, and third parties such as distributors, external service providers, partners (the PV Universe). The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
PV Audit Strategy Planning, The European Medicines Agency's (EMA) Guideline, Good Pharmacovigilance Practices (GVP), risk-based audits, GVP Modules, PV Universe
62.
 
Orphan Drugs and Rare Diseases Europe 2017
ID
852643
Termin
15. Mai 2017 - 16. Mai 2017
Ort
Berlin, Deutschland
Zusammenfassung
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
Kontakt
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Themen
Orphan Drugs, Rare Diseases, Market Access, Pricing and Reimbursement, Patient Recruitment
63.
 
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)
ID
878091
Termin
15. Mai 2017 - 16. Mai 2017
Ort
Boston, Vereinigte Staaten
Zusammenfassung
The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs). These guidances align Process Validation activities with a product lifecycle concept and with existing FDA and EU guidances, including the FDA/International Conference on Harmonization (ICH), Guidance for Industry, Q8 (R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The lifecycle concept, new to these Guidances, link product and process development, qualification of the commercial manufacturing process, and maintenance of the process in a state of control during routine commercial production. These guidances also support process improvement and innovation through sound science and risk management. The new Process Validation Guideline/Practice incorporate elements of Process Validation as early as the Research and Development phase, and continues onward through Technology Transfer, into the Phase 1 IND Clinical Trial manufacturing phase, and ultimately into Phase 2 and 3, and then commercial manufacturing. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA Process Validation Guidance, EU Annex 15, Active Pharmaceutical Ingredients (APIs), International Conference on Harmonization (ICH)
64.
 
Gavin Conferences — International Conference on Pharmaceutical Drugs
ID
848195
Termin
15. Mai 2017 - 17. Mai 2017
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
Gavin Conferences invites participants from all over the world to attend “International Conference on Pharmaceutical Drugs” to be held on May 15-17, 2017 at Dubai, UAE. The conference is organized with the theme “Bridging the gap between Drugs and Disease Prevention” which includes keynote presentations from world class scientists and researchers, Oral talks, Poster presentations, B2B meetings and Exhibitions. World-renowned speakers, the most recent techniques and updates in the field of Pharmaceutics are hallmarks of this conference.
Kontakt
Daniel;     Tel.: [6303970234];     Email: danielgavin456@gmail.com
Themen
Pharmaceutical Drug Development,  Drug Formulation, Evaluation, Drug Discovery, Drug Designing, Drug Delivery Systems, New Manufacturing technologies, Pharmaceutical Industry, Adverse Drug Reactions, Pharmaceutical Business
65.
 
MENA Cold Chain — 4th Annual MENA Pharmaceutical Cold Chain Forum
ID
870085
Termin
16. Mai 2017 - 17. Mai 2017
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
The MENA region continues to face its challenges as most temperature deviations occur during supply chain transportation. The pharmaceutical industry relies heavily on the airline industry for its speed and efficiency. Unfortunately, 57% of deviations happen at the airport premises. Temperature changes during transportation have been a serious threat to the integrity of the products. Shippers in the region are on a constant look out for service providers who can help them maintain the product integrity and efficacy during transportation.
Kontakt
MCI Dubai;     Tel.: [97143116300];     Email: conferences@mci-group.com
Themen
Pharmaceutical
66.
 
Principles of Pharma Market Access in Europe
ID
834294
Termin
16. Mai 2017 - 17. Mai 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
67.
 
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)
ID
878167
Termin
16. Mai 2017 - 17. Mai 2017
Ort
Philadelphia, Vereinigte Staaten
Zusammenfassung
This interactive one-and-a-half-day seminar is intended to educate regulatory and quality professionals regarding the rather complicated regulations that distinguish Non-prescription Drugs from other products such as foods, cosmetics, dietary supplements and prescription drugs that sometimes contain the same ingredients. Recent FDA actions such as the banning of antibacterial soaps and ongoing programs that may impact manufacturers and private label distributors will be discussed. It will explain differences in the way homeopathic and conventional drugs are regulated and update participants on FDA’s application of GMP regulations to manufacturing low risk drugs that could be sold as cosmetics with the same ingredients, but different labeling. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Cosmeceuticals, dietary supplements, cosmetics, homeopathic OTCs, FDA regulations, FDA GMPS, good manufacturing practices, over the counter, low risk OTC drugs, warning letters, FDA enforcements actions, FDA marketing regulations
68.
 
CRISPR Summit
ID
877876
Termin
17. Mai 2017 - 18. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
There is no doubt about it, CRISPR is rapidly changing the way diseases are researched, and will soon revolutionize the way they are treated. However, challenges affecting the use of this technique is halting its overall progress and this summit is ready to address the key issues currently affecting CRISPR research.

Topics for debate will include all aspects of CRISPR, from the different techniques of delivering Cas9 to uncovering how to control the repair pathway. The summit will also be assessing the limitation of CRISPR technique and discover what key developments have allowed progress in understanding the unknown. Sessions on screening and bioinformatics will also be included to see how these tools have helped predict the outcome of the CRISPR/Cas9 system.

Whether you are already underway with using CRISPR in your research, or are considering implementing the technology, this conference is where you need to be in 2017!

Kontakt
Faith Arinaitwe;     Tel.: [+44 (0)207 036 1300];     Email: enquire@iqpc.co.uk
Themen
CRIPSR, CAS 9, In vivo, Gene expression, Gene Editing
Verwandte Fachgebiete
69.
 
Value Pricing for Market Access - The Fundamentals
ID
834388
Termin
18. Mai 2017 - 19. Mai 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
70.
 
Vaccines Global Congress 2017 Europe
ID
873408
Termin
18. Mai 2017 - 19. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
Paradigm Global Events is proud to present its Vaccines Global Congress 2017 Europe. Progress in virology, genetics, synthetic biology, and biotechnology has provided a new set of tools to approach current-day vaccinology, while increased understanding of human immunity and microbes has catalyzed unprecedented advances that can be adopted to improve public health. Despite continuing challenges, the collective effort of governments and nonprofit organizations to expand the utilization of effective vaccines throughout the world has grown.
Kontakt
Jocelyn Raguindin;     Tel.: [02035671321];     Email: rmasseretti@paradigmglobalevents.com
Themen
Epitope, Protein based Vaccine, Vaccine manufacturing, Batch cultivations, Plant Biotechnology, Malaria, HIV, Dengue, Tubercolosis, Hepatitis, Pediatric Vaccines, Vectored Vaccines, Clarification of Vaccines, Aids Vaccines, Economics of Vaccine production, Vaccine Immunotherapy, Dendritic Cell Vaccines, Pancreatic Cancer, Zika Fever, Ebola Virus, Universal Flu Vaccine, TB Vaccines, Alzheimer's disease, Cervical Cancer, Latest developments on new adjuvant technologies and novel immunotherapies in the treatment of cancer and emerging viral diseases, Comprehensive insights on new technological developments in vaccine production, Regulatory approach and economic consideration on vaccine trials.
71.
 
Quality Control Laboratory Compliance - cGMPs and GLPs
ID
878207
Termin
18. Mai 2017 - 19. Mai 2017
Ort
Philadelphia, Vereinigte Staaten
Zusammenfassung
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Quality Control Lab regulations, QC Lab regulations, FDA QC Lab requirements, FDA lab regulations, Good Laboratory Practices, GLP, cGMP, Current Good Manufacturing Practices
72.
 
HPAPI — Highly Potent Active Pharmaceutical Ingredients 2017
ID
854687
Termin
22. Mai 2017 - 23. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.
Kontakt
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Themen
API- Active Pharmaceutical Ingredients, Cytoxic, Potency, HA - Health Agency, PDE - Permitted Daily Exposure, Cross Contamination, Compound, Scale Up
Verwandte Fachgebiete
73.
 
Biologistics World Korea 2017
ID
827164
Termin
23. Mai 2017 - 24. Mai 2017
Ort
Seoul, Republik Korea
Zusammenfassung
Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines. Located in Singapore, the prime logistics hub of Korea, the programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!
Kontakt
Andrew Darwitan;     Tel.: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
74.
 
Learning and Memory: Cellular and Molecular Mechanisms
ID
857966
Termin
28. Mai 2017 - 04. Jun 2017
Ort
Siena, Italien
Zusammenfassung
Recent ground-breaking developments in neuroscience, such as optogenetics, in vivo 2-photon confocal microscopy, head mounted microscopes, powerful new developments in modeling, behavioral neuroscience approaches, and sophisticated brain imaging tools, have changed dramatically studies of memory. Most importantly, these developments have fostered interdisciplinary studies that led to integrated molecular, cellular, systems, cognitive and behavioral explanations of how memories are allocated, formed, consolidated, reconsolidated and retrieved. These studies have also led to mechanistic cross-disciplinary studies of memory disorders, which in some cases led to the development of targeted treatments that are changing how we imagine treating the considerable health burden associated with this large class of conditions.
Kontakt
Francesca Martini;     Tel.: [+39.0577.146.0003];     Email: info@nsas.it
Verwandte Fachgebiete
75.
 
Pre-Filled Syringes West Coast
ID
877261
Termin
05. Jun 2017 - 06. Jun 2017
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
SMi Group are thrilled to announce the return of Pre-Filled Syringes West Coast 2017 which arrives to California on June 5th & 6th.

Following on from sell-out shows in Europe and Boston, Pre-Filled Syringes West Coast will once again gather a global audience of medical device experts and PFS industry leaders to discuss new developments and showcase cutting edge advances, keeping you at the forefront of a booming industry. The competitive PFS market has sparked great improvements as devices strive for higher quality, safety, and patient satisfaction. Innovation and excellence is requested at every level making Pre-Filled Syringes West Coast the perfect platform to strengthen knowledge in key principles such as human factor engineering, manufacturing and complex biologics, whilst honing in on emerging trends for parenteral devices, including auto injectors, pens, pumps and smart devices. We will also be welcoming expertise from the likes of Nemera, Nipro PharmaPackaging, Terumo, Worrell, Zeon, Allergan, MedImmune, Xeris Pharmaceuticals, Amgen, Eli Lilly, Genentech, Ferring, Roche and more.

Kontakt
Teri Arri;     Tel.: [+44 (0)20 7827 6000];     Email: tarri@smi-online.co.uk
Themen
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd, drug delivery, infusion, vial, cop, sterilization, clogging
76.
 
18th Annual Drug Discovery Summit
ID
845356
Termin
12. Jun 2017 - 13. Jun 2017
Ort
Berlin, Deutschland
Zusammenfassung
This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
drug discovery, screening, genomics, biotechnology, pharmaceutical, small molecule, large molecule, technologies
77.
 
ADMET — 12th annual ADMET
ID
873406
Termin
12. Jun 2017 - 13. Jun 2017
Ort
London, Großbritannien
Zusammenfassung
SMi is delighted to announce the 12th annual ADMET conference returning to London in 2017! This event will be discussing new technologies, innovation and developments in the ADMET sector. ADMET technologies determine properties of a drug candidate in the preclinical stage of drug discovery, and poor ADMET properties are a major cause for a candidate to fail in drug development.
Kontakt
Kyra Williams;     Tel.: [02078276012];     Email: kwilliams@smi-online.co.uk
Themen
Admet, Gentotoxic, In Vivio, In Vitro, In Silico, Assay, DMPK, DDI, Metabolites
78.
 
Pharma Engineering 2017 — International Conference on Pharmaceutical and Biomedical Engineering
ID
852666
Termin
12. Jun 2017 - 13. Jun 2017
Ort
Taipei, Taiwan
Zusammenfassung
Conference Series LLC is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “International Conference on Pharmaceutical and Biomedical Engineering” (Pharma Engineering 2017) scheduled to be held during June 12-13, 2017 at Taipei, Taiwan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical and Biomedical Engineering.
Kontakt
Diya Sharan;     Tel.: [7025085200];     Email: pharmaengineering@pharmaceuticalconferences.com
Themen
Pharmaceutical Engineering, Biomedical Engineering, Pharmaceutical Technology, Pharmaceutical Formulations, Drug delivery, Drug Discovery, Genetic Engineering, Tissue Engineering, Bio Imaging, Process Engineering, Pharmaceutical Process Technology Novel drug deliveryNanotechnology Engineering
79.
 
10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
831634
Termin
13. Jun 2017 - 15. Jun 2017
Ort
London, Großbritannien
Kontakt
Renaldo Hawell;     Email: renaldohowell179@gmail.com
Themen
Pharmaceutics/Formulation/Drug Delivery/Vaccine/Novel Drug Delivery
80.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858807
Termin
13. Jun 2017 - 15. Jun 2017
Ort
Edinburgh , Großbritannien
81.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858740
Termin
13. Jun 2017 - 15. Jun 2017
Ort
Chicago, Vereinigte Staaten
82.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864106
Termin
14. Jun 2017 - 16. Jun 2017
Ort
London, Großbritannien
83.
 
FASEB SRC — From Unfolded Proteins in the Endoplasmic Reticulum (ER) to Disease
ID
871011
Termin
18. Jun 2017 - 23. Jun 2017
Ort
Saxtons River, VT, Vereinigte Staaten
Zusammenfassung
This SRC focuses on the endoplasmic reticulum (ER) and its functions. The purpose of the meeting is to merge recent developments in molecular biology, cell biology, genetics, and physiology aimed at unraveling the complexities of secretory protein folding, ER stress pathways, lipid signaling, and ER membrane biology, and how failure of these processes lead to pathologies and disease. This SRC will include talks from outstanding scientists, both invited and selected from poster abstracts. The meeting is known for its active discussions, not only during the presentation session, but also during the free afternoons, and especially during the poster sessions. Posters will remain on display during most of the conference and a selection will be advertised in oral poster pitches. The venue, Vermont Academy, is excellently suited for the mingling of junior and established scientists, which will be strengthened by meet-the-speaker sessions that allow discussions of both career issues and science.
Kontakt
FASEB SRC Staff;     Tel.: [3016347010];     Email: src@faseb.org
Themen
biochemistry, Pharmacology
Verwandte Fachgebiete
84.
 
Health Economics for Non-Health-Economists
ID
834373
Termin
20. Jun 2017 - 21. Jun 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
85.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781835
Termin
20. Jun 2017 - 23. Jun 2017
Ort
Albufeira, Portugal
Zusammenfassung
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Verwandte Fachgebiete
86.
 
BPD 2017 — Bulgarian Pharmaceutical Days 2017
ID
878064
Termin
23. Jun 2017 - 25. Jun 2017
Ort
Ruse, Bulgarien
Zusammenfassung
The Bulgarian Pharmaceutical Days (BPD) is a trademark of the Bulgarian Pharmaceutical Union (BPU). The tradition started back in 1996, and ever since the forum is held annually. From 2007 the event became popular under the trademark “Bulgarian Pharmaceutical Days”. In line with tradition, the event is associated with the celebration of Saint John's Eve, June 24, the Day of Pharmacists in Bulgaria. For the eleventh consecutive year, the 2017 edition of the Bulgarian Pharmaceutical Days will allow you to strengthen your networking with existing and new contacts, to share your experience and to discuss the most important and topical issues in pharmaceutical theory and practice. Over the years the forum was attended by a number of distinguished guests and presenters from the top legislative and executive levels of the Republic of Bulgaria, academia, the Pharmaceutical Group of the European Union, and professional associations of health professionals from this country and from other EU states alike.
Kontakt
Mariana Nedeva;     Tel.: [+359 2 494 94 84];     Email: pharma@newevent.bg
Themen
Pharmaceutic
87.
 
16th Annual Medicinal & Pharmaceutical Sciences Congress (Med Pharma Congress)
ID
852303
Termin
03. Jul 2017 - 05. Jul 2017
Ort
Kuala Lumpur, Malaysia
Zusammenfassung
Conference Series LLC invites all the participants across the globe to attend 16th Annual Medicinal & Pharmaceutical Sciences Congress during July 3-5, 2017 in Kuala Lumpur, Malaysia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Med Pharma Congress is a specially designed cluster Pharma conference. The main theme of this Pharma conferences is “Developing the Synergy between Pharmaceutics and Medicinal Chemistry to Deliver Better Drugs” which covers a wide range of critically important sessions.
Themen
Medicinal Chemistry • Pharmacology • Chromatographic Techniques for Drug Analysis • Synthetic Organic Chemistry • Bio Pharmaceuticals • Pharmacogenomics • Pharmacognosy and Phytochemistry • Pharmaceutical Toxicology • Industrial Pharmacy
Verwandte Fachgebiete
88.
 
How to do Research on Therapeutic Interventions: Protocol Preparation
ID
828710
Termin
03. Jul 2017 - 07. Jul 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The How to do Research on Therapeutic Interventions: Protocol Preparation course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Grant D Vallance, Information Manager at the Oxford University Hospitals NHS Trust, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
89.
 
9th World Congress on BA/BE Studies and Biowaivers
ID
849807
Termin
17. Jul 2017 - 19. Jul 2017
Ort
Melbourne, Australien
Zusammenfassung
Bioequivalence Congress is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.
Kontakt
Daisy Pearl;     Tel.: [(702) 508-5200 Extn-8045];     Email: ba.beasia@pharmaceuticalconferences.org
Themen
drug research, generic drugs, bioequivalence, pharmacology, clinical pharmacology, bcs, biowaivers, pharmcodynamic studies, clinical trails, clinical research, FDA
90.
 
9th International Conference and Exhibition on Pharmacovigilance & Drug Safety
ID
869808
Termin
17. Jul 2017 - 19. Jul 2017
Ort
München, Vereinigte Staaten
Kontakt
programe cordinator;     Tel.: [702-508-5200];     Email: pharmacovigilance@pharmaceuticalconferences.org
Themen
Advanced Regulatory Compliance in Pharmacovigilance operations and innovations Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
91.
 
NanoPharma 2017 — 13th International Conference and Exhibition on Pharmaceutical Nanotechnology
ID
852381
Termin
24. Jul 2017 - 25. Jul 2017
Ort
Rom, Italien
Zusammenfassung
Currently we are bringing forth “13th International Conference and Exhibition on Pharmaceutical Nanotechnology” (NanoPharma 2017) scheduled to be held during July 24-25, 2017 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Drug delivery.
Kontakt
Angela Mathews;     Tel.: [7025085200];     Email: nanopharma@pharmaceuticalconferences.org
Themen
drug delivery, nanoparticles, nanodrugs, nanomedicines, nanopharmaceuticals, pharmaceutical nanotechnology, liposomes, neosomes, erythrosomes
Verwandte Fachgebiete
92.
 
Asia Pharma 2017 — 10th Asia-Pacific Pharma Congress
ID
827423
Termin
24. Jul 2017 - 26. Jul 2017
Ort
Melbourne, Australien
Zusammenfassung
Asia Pharma 2017 is a perfect platform for scientists, decision-makers and students to come together, compare findings, and discuss the science of the future. Share your research with an engaged audience of your peers from around the globe; learn from scientific trail blazers who are designing more sustainable processes; find out how Pharmaceutical innovations are inspiring new businesses and product lines. Pharmaceutical sciences focus on the physiology and chemistry controlling drug therapeutic action in modern medicine. Often confused with pharmacy practice, pharmaceutics is distinct in its research and development emphasis, contributing important technologies and scientific bases for drug delivery to patients. Over half of newly discovered drug candidates cannot be commercialized without further drug delivery and formulation assistance. Researchers trained in pharmaceutics integrate a broad working knowledge of diverse scientific disciplines: from fundamental studies of drug physiochemical properties and bioactive molecules to mechanisms of various physiological processes that impact drug delivery to specific biological sites of action and, therefore, their therapeutic effectiveness. Increasing awareness of the complexity of the drug delivery process in living systems means that researchers in pharmaceutics today must maintain breadth and depth in physical chemistry, physical organic chemistry, bioengineering, nanotechnology and the life sciences in order to solve research problems that require integration basic science concepts from multiple disciplines with medical applications.
Kontakt
Robert Brown;     Tel.: [17025085200];     Email: asiapharma@pharmaceuticalconferences.com
Themen
Regulatory Affairs, Intellectual Property Rights, Pharmacognosy and Phytochemistry, Advancements in Pharmaceutics, Trends in Nanotechnology, Industrial Pharmacy, Pharmacological Studies, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry and Molecular Biology, Clinical Pharmacy, Hospital Pharmacy, Pharmaceutical Care & Health Systems, Pharma Compliance.
93.
 
International Vaccines Congress
ID
857202
Termin
27. Jul 2017 - 28. Jul 2017
Ort
Chicago, Vereinigte Staaten
Zusammenfassung
PULSUS is the publisher of peer reviewed scientific, technical, and medical journals and magazines. Since establishment 1984, has been instrumental in healthcare and medical dissemination. PULSUS expanded with the support from scientific societies and open its arm to conduct global medical and healthcare meetings. With immense please and support, PULSUS is honored to announced it International Vaccines Congress, which will be going to held in Chicago, USA during July 27-28, 2017.
Kontakt
Annah Brwon;     Email: vaccinescongress@protonmail.com
Themen
vaccines Congress, Vaccines Conference 2017, Vaccines Conference USA
Verwandte Fachgebiete
94.
 
Pharmaceutics Meeting 2017 — “Global Experts Meeting on Pharmaceutics & Drug Delivery Systems”
ID
877237
Termin
31. Jul 2017 - 02. Aug 2017
Ort
Melbourne, Australien
Kontakt
swapna sarah;     Tel.: [8001012627];     Email: pharmaceutics@pharmameetings.com
Themen
Pre-Formulation, Formulation Aspects, Pharmacokinetics and Pharmacodynamics, Drug Targeting, Drug Delivery Routes, Nano Drug Delivery Systems, Nanotechnology in Drug Delivery, Pharmaceutical Nanotechnology, Smart Drug Delivery Systems, Applications of Biomaterials, Theranostics and Peptides and Protein Drug Delivery.
95.
 
Pharmacology Studies 2017 — International Conference on Pharmacology & Toxicology Studies
ID
859639
Termin
07. Aug 2017 - 09. Aug 2017
Ort
Philadelphia, Vereinigte Staaten
Zusammenfassung
Scientific Synergy Conferences are delighted to welcome you all to the
Kontakt
Scientific Synergy;     Tel.: [+1-888-623-5051];     Email: pharmacology@scientificsynergy.com
Themen
Pharmacology Studies 2017, Pharmacology Conference, Toxicology Conference, Scientific Synergy USA, Pharmacology Conference Philadelphia, Pharmacology Congress USA, Clinical Pharmacology event, Drug Toxicology, Pharmacology Case Reports, Forensic Toxicology.
96.
 
Biosimilars Asia 2017 — 8th Asian Biosimilars Congress
ID
841101
Termin
14. Aug 2017 - 16. Aug 2017
Ort
Osaka, Japan
Zusammenfassung
Biosimilars Asia 2017 is a specially designed cluster conference. The main theme of the conference is
Kontakt
Victorya Jones;     Tel.: [7025085200];     Email: biosimilarsasia@pharmaceuticalconferences.com
Themen
biosimilars, biologics, biosimilars conference, biologics conferences, biosimilars events, Biologics events, biosimilars workshops
97.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858845
Termin
11. Sep 2017 - 13. Sep 2017
Ort
Clarion Hotel Prague, Tschechische Republik
98.
 
Formulation & Drug Delivery USA Congress
ID
871393
Termin
14. Sep 2017 - 15. Sep 2017
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Oxford Global are proud to present our Formulation & Drug Delivery USA Congress, taking place on 14 – 15 September 2017 in Boston. Over 150 delegates representing leading pharmaceutical organisations, biotech companies and internationally renowned research & academic institutions will be present to discuss and network. Over 40 case studies and presentations focused on exploring regulatory guidelines of both large and small molecule formulations, future applications of protein and peptide formulations, recent advancements in nanoparticles as drug delivery systems, combination drug delivery devices and improving the bioavailability of compounds.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
drug formulation, drug delivery, small molecules, large molecules
99.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864061
Termin
27. Sep 2017 - 29. Sep 2017
Ort
Berlin, Deutschland
100.
 
Principles of Pharma Market Access in Europe
ID
834293
Termin
03. Okt 2017 - 04. Okt 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
101.
 
Value Pricing for Market Access - The Fundamentals
ID
834398
Termin
05. Okt 2017 - 06. Okt 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
102.
 
Safety & Selectivity in the Scale-Up of Chemical Reactions
ID
858843
Termin
09. Okt 2017 - 10. Okt 2017
Ort
Lisbon , Portugal
103.
 
Scaling from Milligrams to 1-2kg: Making the First GMP Batch
ID
858831
Termin
09. Okt 2017 - 10. Okt 2017
Ort
Lisbon , Portugal
104.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858885
Termin
11. Okt 2017 - 13. Okt 2017
Ort
Lisbon , Portugal
105.
 
Health Economics for Non-Health-Economists
ID
834350
Termin
12. Okt 2017 - 13. Okt 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
106.
 
PHARMATechExpo — VIII International Exhibition of Equipment and Technologies for the Pharmaceutical Industry
ID
877240
Termin
17. Okt 2017 - 19. Okt 2017
Ort
Kiew, Ukraine
Zusammenfassung
The only one Exhibition in Ukraine where is presented the entire pharmaceutical production process: from development of substances and quality control of raw materials, equipment for pharmaceutical production and packaging technologies to transportation, storage of pharmaceuticals and staff recruitment. During the exhibition, in the framework of the scientific-practical program Days of pharmaceutical industry will be held conferences, seminars, round tables and presentations.
Kontakt
Olga Babii;     Tel.: [+380442061015];     Email: expo@pharmatechexpo.com.ua
Themen
raw materials and components, production and nonproduction equipment, packing and packing equipment, сlean rooms technologies, technologies and equipment for water supply, water treatment and sewage treatment, industrial refrigeration and climatic equipment for pharmaceutical enterprises, staff training and educational institutions, services for pharmaceutical companies
107.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864137
Termin
18. Okt 2017 - 20. Okt 2017
Ort
London, Großbritannien
108.
 
MedTechConf Sarajevo
ID
868311
Termin
19. Okt 2017 - 20. Okt 2017
Ort
Sarajevo, Bosnien und Herzegowina
Kontakt
Edina Musmulja;     Tel.: [+ 387 61 914 178];     Email: info@medtechconf.com
Themen
Regenerative Medicine & Biological Materials, Future Drugs, Three-dimensional Echocardiography, Neuroscience, Health Economics, Artificial Intelligence & New Technology Development, Future Healthcare Ecosystems & Medical Billing
109.
 
ICCP — 5th International Conference on Clinical Pharmacy
ID
858171
Termin
23. Okt 2017 - 24. Okt 2017
Ort
Florida, Vereinigte Staaten
Zusammenfassung
Clinical Pharmacy Conference aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results about all aspects of Clinical Pharmacy. It also provides the disciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Clinical Pharmacy. All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers, and e-posters. Also, high-quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Clinical Pharmacy are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers, and e-posters that address themes and topics of the conference, including figures, tables, and references of novel research material. The conference abstracts and proceedings book and certificate of presentation will be distributed to the conference participants at the conference registration desk. In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of biomedical, pharmaceutical, and clinical sciences by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Clinical Pharmacy.
Kontakt
Victor Badoni;     Tel.: [7025085200 Ext: 8047];     Email: badonivictor@outlook.com
Themen
Pharma Conferences, Pharmacy Conferences, Clinical Pharmacy Conferneces, Pharmaceutical Conferences
110.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858840
Termin
31. Okt 2017 - 02. Nov 2017
Ort
Boston , Vereinigte Staaten
111.
 
International Pharmaceutical Conference and Expo
ID
875932
Termin
14. Nov 2017 - 16. Nov 2017
Ort
Philadelphia,, Vereinigte Staaten
Zusammenfassung
iPharma 2017 cordially welcomes you to the City of Philadelphia, USA during November 14-16, 2017. Conference will witness academicians and business professionals discussing the soundest issues related to pharmaceuticals and will offer unparalleled business opportunities and access to new markets in Health Science.
Kontakt
serena martin;     Tel.: [6193784793];     Email: serena@ipharmaconference.com
Themen
Pharmaceutical, Drug Discovery, Drug Delivery Systems, Pharmaceutical Nanotechnology, Drug Therapy, Pharmaceutical Formulations, Clinical Trials, Neuropharmacology, Biopharmaceutical, Nutraceuticals, Pharma Medicines
112.
 
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
879190
Termin
27. Nov 2017 - 28. Nov 2017
Ort
Atlanta, Georgien
Zusammenfassung
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Kontakt
Safina Robinson;     Tel.: [2037691765];     Email: biomarkers@cmesocietyconferences.org
Themen
Biomarkers Conference, Biomarkers Conference 2017, Biomarkers Conferences, Cancer Biomarkers Conference, Biomarker Conferences, Cancer Biomarker Conferences, Biomarkers Congress 2017, Biomarkers Society Conferences, Biomarker Conferences 2017
113.
 
Biomarkers congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
867762
Termin
27. Nov 2017 - 28. Nov 2017
Ort
Atlanta, Vereinigte Staaten
Zusammenfassung
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Kontakt
Rachel Mathews;     Email: america@cmesociety.com
Themen
Biomarkers Conference, Biomarkers Conference 2017, Biomarkers Conference December, Cancer Biomarkers, Cancer Conferences, Cancer Conferences 2017, Biomarkers Events, Biomarkers Society Conferences, Biomarkers Congress
Verwandte Fachgebiete
114.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864125
Termin
27. Nov 2017 - 29. Nov 2017
Ort
Berlin, Irland
115.
 
 International summit on — Medical, Pharma & drug studies
ID
875679
Termin
29. Nov 2017 - 30. Nov 2017
Ort
Brisbane, Australien
Zusammenfassung
The Innovate Medicine 2017 team is the premier medical conference event producer. At these medical conference events, physicians, Hospital & Clinical professionals, Medical Students are able to latest updates in Medical Pharma & Drug Research Studies insights, explore new challenges in health care, surgeries, hospital management, medical treatment and care as well as review clinical case studies in order to understand how best to deal with specific situations
Kontakt
aarondurant;     Tel.: [61-1-800-025-686];     Email: pharma@innovatecolloquium.com
116.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834323
Beginn
30. Nov 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
117.
 
Digital Pathology Congress
ID
877157
Termin
30. Nov 2017 - 01. Dez 2017
Ort
London, Großbritannien
Zusammenfassung
The conference is part of the successful Personalised Medicine series which includes events on precision medicine, synthetic biology, the human microbiome, biologics and digital PCR. The meeting is also the sister meeting to the US and Asian Digital Pathology meetings taking place in July and August respectively.
Kontakt
Jane Wiliams;     Email: jane@globalengage.co.uk
118.
 
Principles of Pharma Market Access in Europe
ID
834314
Termin
05. Dez 2017 - 06. Dez 2017
Ort
London, Großbritannien
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
119.
 
Value Pricing for Market Access - The Fundamentals
ID
834331
Termin
07. Dez 2017 - 08. Dez 2017
Ort
London, Großbritannien
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
120.
 
Health Economics for Non-Health-Economists
ID
834404
Termin
14. Dez 2017 - 15. Dez 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
121.
 
Eilat XIV — Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices
ID
839583
Termin
13. Mai 2018 - 16. Mai 2018
Ort
Madrid, Spanien
Zusammenfassung
Based on the success of the past thirteen Eilat Conferences on New Antiepileptic Drugs and Devices (AEDs), the Organizing Committee takes pleasure in inviting you to participate in the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV), which will take place in Madrid, Spain, May 13 - 16, 2018.

For the forthcoming conference, we will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.

Kontakt
Vikki Hyman;     Tel.: [+97235175150];     Email: eilat@target-conferences.com
Themen
epilepsy, antiepileptic, drugs, devices, treatments, conference, congress
Verwandte Fachgebiete
RNA Therapeutics conference
Superbugs & Superdrugs Conference
Pharmaceutical Freeze Drying Technology, 8th & 9th May 2017, Copthorne Tara Hotel, London UK
Pain Therapeutics, 22nd & 23rd May 2017, Copthorne Tara Hotel, London UK
Pre-Filled Syringes West Coast, 5th & 6th June 2017, Hyatt Regency Mission Bay, San Diego, California, USA

Interessant...

Ihr Banner-Ad könnte an dieser Stelle erscheinen!

Stand vom 21. Februar 2017